Latest news
25 items- PRNextPlat Invests $7 Million in Recapitalization of Progressive Care Inc.Investment to Accelerate Progressive's Digital Healthcare Transformation and Launch of Global E-Commerce Platform for New Healthcare Products for Domestic and International MarketsCOCONUT GROVE, FL / ACCESSWIRE / August 31, 2022 / NextPlat Corp (NASDAQ:NXPL, NXPLW))) ("NextPlat" or the "Company"), a global e-commerce provider today announced that it has completed a strategic $7 million investment in Progressive Care Inc. (OTCQB:RXMD), a personalized healthcare services and technology company ("Progressive Care").Under the recapitalization plan, NextPlat Corp, its Executive Chairman and CEO, Charles M. Fernandez, and board member, Rodney Barreto, and certain other investors will invest an agg
- INSIDERSEC Form 4: Barreto Rodney was granted 20,000 shares, increasing direct ownership by 5% to 390,371 units4 - NextPlat Corp (0001058307) (Issuer)
- INSIDERSEC Form 3: New insider Barreto Rodney claimed ownership of 370,371 shares3 - NextPlat Corp (0001058307) (Issuer)
- SECOrbsat Corp filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits (Amendment)8-K/A - ORBSAT CORP (0001058307) (Filer)
- SECOrbsat Corp filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORBSAT CORP (0001058307) (Filer)
- NEWSOrbsat Corp Initiates Transition To NextPlat Effective January 21, 2022Orbsat Corp (NASDAQ:OSAT)(NASDAQ:OSATW) ("Orbsat" or the "Company"), a global e-commerce provider, today announced that it has changed its corporate name to NextPlat Corp ("NextPlat") with an effective date of January 21, 2022 ("Effective Date"). The website for NextPlat will be www.nextplat.com. In connection with the corporate name change, the Company's Common Stock will begin trading on January 21, 2022, under the new ticker symbol "NXPL" and will retain the current CUSIP of 68557F209, and the Company's Warrants will begin trading on January 21, 2022, under the new ticker symbol "NXPLW" and will retain the current CUSIP of 68557F118. The corporate name change does not affect the ongoing
- 13D/GSEC Form SC 13D/A filed by Orbsat Corp (Amendment)SC 13D/A - ORBSAT CORP (0001058307) (Subject)
- 13D/GSEC Form SC 13G/A filed by Orbsat Corp (Amendment)SC 13G/A - ORBSAT CORP (0001058307) (Subject)
- SECSEC Form D filed by Orbsat CorpD - ORBSAT CORP (0001058307) (Filer)
- SECOrbsat Corp filed SEC Form 8-K: Leadership Update8-K - ORBSAT CORP (0001058307) (Filer)
- PROrbsat Appoints Rodney Barreto to Board of DirectorsBarreto Brings Decades of Public Affairs, Consulting, and Business Development Expertise to Orbsat as it Accelerates its Transition into NextPlat, a Global E-Commerce Platform CompanyAVENTURA, FL / ACCESSWIRE / January 11, 2022 / Orbsat Corp (NASDAQ:OSAT, OSATW))) ("Orbsat" or the "Company"), a global e-commerce provider, today announced the appointment of Rodney Barreto to its Board of Directors effective January 20, 2022.Mr. Barreto is an accomplished and recognized executive and business leader with over 35 years of experience in corporate and public affairs, real estate investment, development, and hospitality throughout South Florida. He is currently the President and CEO of the Barreto
- NEWS4 Penny Stocks Insiders Are BuyingWhen insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. InMed Pharmaceuticals The Trade: InMed Pharmaceuticals Inc. (NASDAQ:INM) SVP Aaron Shane Johnson acquired a total of 8500 shares at an average price of $1.26. To acquire these shares, it cost $10,710.00. What’s Happening: InMed Pharmaceuticals recently announced publication of article on CBN as possible glauc
- INSIDERSEC Form 4: Ellenoff Douglas bought $150,002 worth of shares (46,297 units at $3.24)4 - ORBSAT CORP (0001058307) (Issuer)
- INSIDERSEC Form 4: Cusimano Louis bought $50,003 worth of shares (15,433 units at $3.24), increasing direct ownership by 77% to 35,433 units4 - ORBSAT CORP (0001058307) (Issuer)
- INSIDERSEC Form 4: Thomson Paul R bought $50,003 worth of shares (15,433 units at $3.24), increasing direct ownership by 77% to 35,433 units4 - ORBSAT CORP (0001058307) (Issuer)
- INSIDERSEC Form 4: Phipps David bought $150,002 worth of shares (46,297 units at $3.24), increasing direct ownership by 13% to 393,288 units4 - ORBSAT CORP (0001058307) (Issuer)
- NEWSOrbsat Form 4 Filing From Co. Chair, CEO Shows Purchase Of ~679K Shares Of Co. Stock At $3.24/Share
- INSIDERSEC Form 4: Fernandez Charles M. bought $2,200,002 worth of shares (679,013 units at $3.24), increasing direct ownership by 67% to 1,686,953 units4 - ORBSAT CORP (0001058307) (Issuer)
- SECOrbsat Corp filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - ORBSAT CORP (0001058307) (Filer)
- NEWS61 Biggest Movers From YesterdayGainers Genprex, Inc. (NASDAQ:GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination therapy. Immix Biopharma, Inc. (NASDAQ:IMMX) shares jumped 62.4% to close at $5.78 on Monday. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer. Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) surged 44.8% to settle at $3.20. The stock may be seeing increased interested from retail investors. Armstrong Flooring, Inc. (NYSE:AFI) jumped 39.9% to close at $2.77 as the company said it received
- NEWS35 Stocks Moving In Monday's Mid-Day SessionGainers Immix Biopharma, Inc. (NASDAQ:IMMX) shares climbed 110.3% to $7.32. The FDA granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma's IMX-110 for rhabdomyosarcoma, a form of pediatric cancer. Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) gained 48.6% to $3.2850. The stock may be seeing increased interested from retail investors. Pear Therapeutics, Inc. (NASDAQ:PEAR) shares climbed 34.7% to $8.35. BTIG initiated coverage on Pear Therapeutics with a Buy rating and announced a price target of $12. Armstrong Flooring, Inc. (NYSE:AFI) rose 25.3% to $2.48 as the company said it received $35 million capital infusion, and announced process for sale
- NEWSOrbsat Announces $7.2M Private Placement, Will Sell 2.23M Shares of Stock for $3.24/Share
- PROrbsat Announces $7.2M Private Offering of Common Stock & Initial Transition to NextPlatOver 73% of Financing Secured From Senior Management, Board Members and Existing ShareholdersAVENTURA, FL / ACCESSWIRE / January 3, 2022 / Orbsat Corp (NASDAQ:OSAT, OSATW))) ("Orbsat" or the "Company"), a global e-commerce provider of IoT and connectivity solutions through next-generation satellite technology, today announced that it executed a binding Securities Purchase Agreement on January 2, 2022 with a number of investors, pursuant to which the Company agreed to sell 2,229,950 shares of common stock at price of $3.24 per share, the closing transaction price reported by Nasdaq on December 31, 2021. Orbsat will receive gross proceeds of approximately $7.2 million. The transaction is expec
- NEWS15 Stocks Moving in Monday's Pre-Market SessionGainers IceCure Medical Ltd (NASDAQ:ICCM) rose 36.5% to $3.89 in pre-market trading. IceCure Medical, last week, received notice of intention to grant a European patent covering its cryogenic pump. American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 25.8% to $2.39 in pre-market trading after dipping 24% on Thursday. RISE Education Cayman Ltd (NASDAQ:REDU) rose 15.3% to $0.6106 in pre-market trading following a 5% surge on Thursday. Genocea Biosciences, Inc. (NASDAQ:GNCA) shares rose 12.5% to $1.40 in pre-market trading after gaining around 20% on Thursday. Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 9.8% to $2.90 in pre-market trading. Aridis Pharmaceuticals, last week
- SECOrbsat Corp filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - ORBSAT CORP (0001058307) (Filer)
OSAT FAQ
5 questionsWhat does Orbsat Corp do?
Orbsat Corp., together with its subsidiaries, provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services in the United States and internationally. Its solutions include satellite communications, IoT tracking, and Internet, as well as emergency locator beacons. The company also provides tracking and monitoring solutions using automatic identification system, 2G-5G, push-to-talk, and two-way radio technology; and sells MSS related equipment. In addition, it operates...Where does OSAT stock trade?
Orbsat Corp (OSAT) is listed on NASDAQ.What sector and industry is OSAT in?
Orbsat Corp operates in the Capital Goods sector, Telecommunications Equipment industry.What companies are similar to OSAT?
Notable peers in the same industry include TMUS (T-Mobile US Inc.), VZ (Verizon Communications Inc.), T (AT&T Inc.), GLW (Corning Incorporated), AMX (America Movil S.A.B. de C.V.). Compare OSAT side-by-side with any of them on Quantisnow.How can I track OSAT on Quantisnow?
Quantisnow aggregates Orbsat Corp's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow OSAT to receive live email and push alerts on every new disclosure.